Global incidence and prevalence of nonalcoholic fatty liver disease
Clinical and Molecular Hepatology · 28.02.2023 · 29 (Suppl) · S32-S42
DOI: 10.3350/cmh.2022.0365 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 28.02.2023. Verfasst von Margaret Lp Teng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 725-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compared to females (26%). The global prevalence of NAFLD has increased over time, from 26% in studies from 2005 or earlier to 38% in studies from 2016 or beyond. The prevalence of NAFLD varies substantially by world region, contributed by differing rates of obesity, and genetic and socioeconomic factors. The prevalence of NAFLD exceeds 40% in the Americas and South-East Asia. The prevalence of NAFLD is projected to increase significantly in multiple world regions by 2030 if current trends are left unchecked. In this review, we discuss trends in the global incidence and prevalence of NAFLD and discuss future projections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore.
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- National University Centre for Organ Transplantation, National University Hospital, Singapore.
- Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Zitieren
APA
Teng, M. L., Ng, C. H., Huang, D. Q., Chan, K. E., Tan, D. J., Lim, W. H., Yang, J. D., Tan, E., & Muthiah, M. D. (2023). Global incidence and prevalence of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology, 29(Suppl), S32-S42. https://doi.org/10.3350/cmh.2022.0365
Vancouver
Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology. 2023;29(Suppl):S32-S42. doi:10.3350/cmh.2022.0365
BibTeX
@article{Teng2023,
author = {Teng, Margaret Lp and Ng, Cheng Han and Huang, Daniel Q and Chan, Kai En and Tan, Darren Jh and Lim, Wen Hui and Yang, Ju Dong and Tan, Eunice and Muthiah, Mark D},
title = {Global incidence and prevalence of nonalcoholic fatty liver disease},
journal = {Clinical and Molecular Hepatology},
year = {2023},
volume = {29},
number = {Suppl},
pages = {S32--S42},
doi = {10.3350/cmh.2022.0365}
}
EUVIMED